Increasing Prevalence and Direct Health Care Cost of Inflammatory Bowel Disease Among Adults: A Population-Based Study From a Western Canadian Province
| Autor: | J A Osei, Gilaad G. Kaplan, Juan Nicolás Peña-Sánchez, Lisa M. Lix, Nazeem Muhajarine, Sharyle Fowler |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Crohn’s disease
0301 basic medicine business.industry Direct health care costs 1. No poverty Original Articles medicine.disease Inflammatory bowel disease digestive system diseases 3. Good health Population based study 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Ulcerative colitis Environmental health Health care cost Prevalence Medicine 030211 gastroenterology & hepatology business AcademicSubjects/MED00260 |
| Zdroj: | Journal of the Canadian Association of Gastroenterology |
| ISSN: | 2515-2092 2515-2084 |
| DOI: | 10.1093/jcag/gwab003 |
| Popis: | Objectives Our study aimed to calculate the prevalence and estimate the direct health care costs of inflammatory bowel disease (IBD), and test if trends in the prevalence and direct health care costs of IBD increased over two decades in the province of Saskatchewan, Canada. Methods We conducted a retrospective population-based cohort study using administrative health data of Saskatchewan between 1999/2000 and 2016/2017 fiscal years. A validated case definition was used to identify prevalent IBD cases. Direct health care costs were estimated in 2013/2014 Canadian dollars. Generalized linear models with generalized estimating equations tested the trend. Annual prevalence rates and direct health care costs were estimated along with their 95% confidence intervals (95%CI). Results In 2016/2017, 6468 IBD cases were observed in our cohort; Crohn’s disease: 3663 (56.6%), ulcerative colitis: 2805 (43.4%). The prevalence of IBD increased from 341/100,000 (95%CI 340 to 341) in 1999/2000 to 664/100,000 (95%CI 663 to 665) population in 2016/2017, resulting in a 3.3% (95%CI 2.4 to 4.3) average annual increase. The estimated average health care cost for each IBD patient increased from $1879 (95%CI 1686 to 2093) in 1999/2000 to $7185 (95%CI 6733 to 7668) in 2016/2017, corresponding to an average annual increase of 9.5% (95%CI 8.9 to 10.1). Conclusions Our results provide relevant information and analysis on the burden of IBD in Saskatchewan. The evidence of the constant increasing prevalence and health care cost trends of IBD needs to be recognized by health care decision-makers to promote cost-effective health care policies at provincial and national levels and respond to the needs of patients living with IBD. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|